Compare GM & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GM | ELV |
|---|---|---|
| Founded | 1908 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3B | 76.5B |
| IPO Year | 2010 | 2001 |
| Metric | GM | ELV |
|---|---|---|
| Price | $75.31 | $293.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 18 |
| Target Price | $89.86 | ★ $383.65 |
| AVG Volume (30 Days) | ★ 6.8M | 2.0M |
| Earning Date | 04-28-2026 | 04-21-2026 |
| Dividend Yield | 0.94% | ★ 2.32% |
| EPS Growth | N/A | ★ N/A |
| EPS | 3.27 | ★ 25.21 |
| Revenue | $185,019,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $3.62 | N/A |
| Revenue Next Year | $2.30 | $2.97 |
| P/E Ratio | $23.38 | ★ $11.79 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $41.60 | $273.71 |
| 52 Week High | $87.62 | $458.75 |
| Indicator | GM | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 41.85 |
| Support Level | $72.09 | $274.33 |
| Resistance Level | $84.26 | $301.00 |
| Average True Range (ATR) | 1.82 | 7.00 |
| MACD | 0.43 | 2.34 |
| Stochastic Oscillator | 51.94 | 71.58 |
General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2025 US share was 17.5%. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.